Table 2.
Number of papers published in PubMed since 2010 reporting on patient reported outcomes (PROs) in oncology clinical trials.
| Tumor type | No. publications listed in PubMed |
|---|---|
| Bladder | 37 |
| Brain | 156 |
| Breast | 1575 |
| Cervical | 41 |
| Colorectal | 301 |
| Gastric | 108 |
| Head/Neck | 330 |
| Leukemia | 95 |
| Lung | 378 |
| Melanoma | 52 |
| Mesothelioma | 21 |
| Multiple myeloma | 49 |
| Myelodysplastic syndrome | 24 |
| Non-Hodgkin’s lymphoma | 48 |
| Ovarian | 113 |
| Pancreatic | 113 |
| Prostate | 432 |
| Renal | 51 |
| Skin, basal cell carcinoma | 2 |
| Soft tissue sarcoma | 21 |
| Thyroid | 17 |
| Uterine | 114 |
Note. PubMed search was conducted for clinical trials using search terms for the specified tumor type and PROs and/or quality of life. Articles were restricted from 2010 through the date of search, March 16, 2018.